CAS: 37321-09-8; Apramycin

该化合物是一种主要用于兽医特别是牲畜感染治疗的动物药物中的微粒球菌抗生素,主要用于兽药,特别是牲畜感染的治疗;它源于细菌* 微生物spora purpurea*, 并展示了广泛的抗菌活动,特别是针对格拉姆阴性细菌的抗菌活动;通过抑制细菌蛋白合成,抑制与30S 脊髓膜炎分元素结合,从而破坏翻译过程的抗菌素功能;这种抗生素以其对某些菌株(* 肝脏科* 和* 沙门氏菌*) 的功效而著称,这在管理动物肠胃感染方面很有价值;阿帕米辛通常通过注射或口服途径进行,其特点是动物毒性相对较低;然而,由于对食物生产动物的抗生素耐药性和潜在残留物的担忧,因此在食品产品中作用受到管制.与其他微分泌物分泌物分泌毒和毒害性作用,因此有必要监测这些风险与其他物种的类别相比,但这些风险一般较低.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    📜Benzyl N-[(2R,3S,4R,4Ar,6S,7R,8As)-2-[(2R,3R,4S,5R,6S)-5-Azido-3,4-Bis(Phenylmethoxy)-6-(Phenylmethoxymethyl)Oxan-2-Yl]Oxy-6-[(1R,2R,3S,4R,6S)-2,3-Dihydroxy-4,6-Bis(Phenylmethoxycarbonylamino)Cyclohexyl]Oxy-4-Hydroxy-7-(Phenylmethoxycarbonylamino)-2,3,4,4A,6,7,8,8A-octahydropyrano[3,2-B]Pyran-3-Yl]-N-Methylcarbamate置于钯 氢气体系中,用 1,4-二氧六环,水,溶剂黄146 用作溶剂,化学反应 2.0H,以74%的收率获得安普霉素
    参考文献:Total Synthesis Of Aminoglycoside Antibiotics,Apramycin And Saccharocin (Ka-5685)
    标题:Total Synthesis Of Aminoglycoside Antibiotics,Apramycin And Saccharocin (Ka-5685)
    摘要:阿普拉霉素和蔗糖霉素(ka-5685)已从先前合成的尼阿霉素(3)合成.将烯丙基氯化镁添加到4-O-[3',4'-O-环己叉-2'-脱氧-2'-(对甲苯磺酰氨基)-α-D-葡六双醛-1',5'-吡喃糖基]-5,6-O-环己叉-1,3-二-N-对甲苯磺酰-2-脱氧链霉胺(由3通过6'-N-氧化物衍生得到),得到4-O-[3',4'-O-环己叉-2',7',8',9'-四脱氧-2'-(对甲苯磺酰氨基)-L-甘油和d-甘油-α-D-葡-8'-烯吡喃糖基]-5,6-O-环己叉-1,3-二-N-对甲苯磺酰-2-脱氧链霉胺,后者又转化为4-O-[(8's)-7'-N,6'-O-羰基-2',3',7'-三脱氧-8'-O-甲基-7'-(甲氨基)-2'-(对甲苯磺酰氨基)-D-甘油-α-D-别辛双醛-1',5':8',4'-双吡喃糖基]-5,6-O-环己叉-1,3-二-N-对甲苯磺酰-2-脱氧链霉胺(25),通过1-N-乙酰基-4-O-[3',6'-二-O-乙酰基-4',8'-无水-2',7'-二脱氧-2'-(对甲苯磺酰氨基)-L-甘油-α-D-葡-7'-烯吡喃糖基]-5,6-O-环己叉-1,3-二-N-对甲苯磺酰-2-脱氧链霉胺的叠氮化硝化和6'-羟基的差向异构化.25的连续脱保护得到阿普拉霉素,从中制备了1,2',3,7'-四(n-苄氧羰基)阿普拉霉素(28),以及28与4-叠氮-2,3,6-三-O-苄基-4-脱氧-β-D-吡喃葡糖基氟或2,3,4,6-四-O-苄基-β-D-吡喃葡糖基氟的糖基化,随后进行氢解,完成了全合成.
    Doi:10.1246/bcsj.57.529

    海关参考信息

    专利信息


    专利号:US-10920229-B2
    优先权日:2014-07-16
    标 题:Method for improving heterologous synthesis of Escherichia coli into polyketides and use of same
    发明人:WANG YONG; XIONG ZHIQIANG; SONG SHUJIE; LIU QIAOXIA; WANG JIANFENG
    权利人:SHANGHAI INST BIOLOGICAL SCIENCES CAS; CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES
    摘要:The present invention relates to a method for improving the heterologous synthesis of a polyketide by E. coli and use thereof. The yield of the polyketide heterologously synthesized by E. coli is significantly increased by attenuating the expression of seventy-two genes, such as sucC and talB, in a host strain, wherein the highest yield increase rate can reach 60% or more. Currently, erythromycin is the most clear model compound in the study on the biosynthesis of polyketids. The production strain of the present invention enables massive accumulation of 6-deoxyerythronolide (6-dEB), an erythromycin precursor, in the fermentation process, laying the foundation for the industrial production of the heterologous synthesis of erythromycin by E. coli.

    专利号:US-9873905-B2
    优先权日:2014-03-07
    标题:Chemoenzymatic synthesis of trehalose analogs
    发明人:SWARTS BENJAMIN M; WOODRUFF PETER
    权利人:CENTRAL MICHIGAN UNIV; UNIV OF MAINE SYSTEM
    摘要:The present invention provides methods of synthesizing trehalose analogs; methods of detecting mycobacteria, and trehalose analogs.

    专利号:US-2008044860-A1
    优先权日:2003-11-28
    标题 :Polyketides and Their Synthesis
    发明人:GAISSER SABINE; HAYDOCK STEPHEN FREDERICK; LEADLAY PETER FRANCIS; MCARTHUR HAMISH ALASTAIR IRVIN
    权利人:GAISSER SABINE; HAYDOCK STEPHEN FREDERICK; LEADLAY PETER FRANCIS; MCARTHUR HAMISH ALASTAIR IRVIN
    摘要:Macrolides particularly erythromycins and azithromycins, having O-mycaminosyl or O-angolosaminyl groups, particularly at the 5 -position, are produced using a gene cassette comprising a combination of genes which, in an appropriate strain background, are able to direct the synthesis of mycaminose or angolosamine and to direct its subsequent transfer to an aglycone or pseudoaglycone. Synthetic genes may comprise one or more of angMIII, angMI, angB, angAI, angAII, angorf14, angorf4, tylMIII, tylMI, tylB, tylAI, tylAII, eryCVI, spnO, eryBVI, eryK, tyl Ia and ery G. Glycosyltransfer genes may comprise one or more of eryCIII, tylMII, angMII, desVII, eryBV, spnP and midI.

    专利号:US-11981938-B2
    优先权日:2017-10-05
    标 题 :Microorganisms and methods for the fermentation of cannabinoids
    发明人:SZAMECZ BELA KRISZTIAN; VARSZEGI SZILVIA; NEMETH ATTILA; SZABO LORAND; KUMAR ABHINAV
    权利人:ELESZTO GENETIKA INC
    摘要:Disclosed herein are microorganism and methods that can be used for the synthesis of cannabigerolic acid (CBGA) and cannabinoids. The methods disclosed can be used to produce CBGA, Δ9-tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabichromenic acid (CBCA), Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannabichromene (CBC). Enzymes useful for the synthesis of CBGA and cannabinoids, include but are not limited to acyl activating enzyme (AAE1), polyketide synthase (PKS), olivetolic acid cyclase (OAC), prenyltransferase (PT), THCA synthase (THCAS), CBDA synthase (CBDAS), CBCA synthase (CBCAS), HMG-Co reductase (HMG1), and/or farnesyl pyrophosphate synthetase (ERG20). The microorganisms can also have one or more genes disrupted, such as gene that that controls beta oxidation of long chain fatty acids.

    专利号:US-2022170057-A1
    优先权日:2019-04-11
    标题:Microorganisms and methods for the fermentation of cannabinoids
    发明人:SZAMECZ BELA KRISZTIAN; VARSZEGI SZILVIA; NEMETH ATTILA; SZABO LORAND
    权利人:ELESZTO GENETIKA INC
    摘要:Disclosed herein are microorganism and methods that can be used for the synthesis of cannabigerolic acid (CBGA) and cannabinoids. The methods disclosed can be used to produce CBGA, Δ 9 -tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabichromenic acid (CBGA), Δ 9 -tetrahydrocannabivarinic acid (THCVA), cannabidivarinic acid (CBDVA), cannabichromevarinic acid (CBCVA), Δ 9 -tetrahydrocannabinol (THC), cannabidiol (CBD), cannabichromene (CBC). Enzymes useful for the synthesis of CBGA and cannabinoids, include but are not limited to acyl activating enzyme (AAE1), polyketide synthase (PKS), olivetolic acid cyclase (OAC), prenyltransferase (PT), THCA synthase (THCAS), CBDA synthase (CBDAS), CBC A synthase (CBCAS), HMG-Co reductase (HMG1), and/or famesyl pyrophosphate synthetase (ERG20). The microorganisms can also have one or more genes disrupted, such as gene that that controls beta oxidation of long chain fatty acids.

    专利号:US-7595156-B2
    优先权日:2003-10-23
    标 题:Genes for synthesis of FR-008 polyketides
    发明人:LEE SANG YUP; DENG ZIXIN; CHEN SHI; JEONG KI JUN; ZHOU XIUFEN
    权利人:KOREA ADVANCED INST SCI & TECH
    摘要:The present invention relates to the base sequence of whole genes involved in the biosynthesis of FR-008 polyketides derived from Streptomyces sp. FR-008. This base sequence comprises genes coding for ketosynthase (KS), acyl transferase (AT), acyl carrier protein (ACP), ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, sugar synthetic protein, FAD-dependent monooxygenase, 4-amino-4-deoxychorismate (ADC) synthase and ADC lyase. The gene base sequence according to the present invention can be used to increase the productivity of the existing FR-008 polyketides or produce new FR-008 polyketides, through modification of its parts.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    1. Riedel S, Vijayakumar D, Berg G, Kang AD, Smith KP, Kirby JE. Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae. J Antimicrob Chemother. 2019 May 1;74(5):1311-1316. doi: 10.1093/jac/dkz012. 2. Juhas M, Widlake E, Teo J, Huseby DL, Tyrrell JM, Polikanov YS, Ercan O, Petersson A, Cao S, Aboklaish AF, Rominski A, Crich D, Böttger EC, Walsh TR, Hughes D, Hobbie SN. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. J Antimicrob Chemother. 2019 Apr 1;74(4):944-952. doi: 10.1093/jac/dky546.

    合成参考文献


    参考文献:10.1186/1471-2180-11-164
    摘要:Pan Y, Wang L, He X, Tian Y, Liu G, Tan H. SabR enhances nikkomycin production via regulating the transcriptional level of sanG, a pathway-specific regulatory gene in Streptomyces ansochromogenes. BMC Microbiology. 2011 Jul 20;11(1):164. doi: 10.1186/1471-2180-11-164.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知